View Filing Data

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2013	Feb. 28, 2014	Jun. 28, 2013
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY
Entity Registrant Name	HEALTHSTREAM INC
Entity Central Index Key	0001095565
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		27,420,090
Entity Public Float			$ 514.3

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 59,537	$ 41,365
Marketable securities	48,659	51,952
Accounts receivable, net of allowance for doubtful accounts of $211 and $142 at December 31, 2013 and 2012, respectively	25,314	15,348
Accounts receivable - unbilled	1,392	1,163
Deferred tax assets, current		2,459
Prepaid royalties, net of amortization	8,857	3,738
Other prepaid expenses and other current assets	3,365	2,266
Total current assets	147,124	118,291
Property and equipment:
Equipment	21,631	18,108
Leasehold improvements	5,521	5,050
Furniture and fixtures	3,854	3,368
Property and equipment, gross	31,006	26,526
Less accumulated depreciation and amortization	(21,968)	(18,706)
Total, property and equipment	9,038	7,820
Capitalized software development, net of accumulated amortization of $13,910 and $10,987 at December 31, 2013 and 2012, respectively	11,077	9,732
Goodwill	35,746	29,299
Intangible assets, net of accumulated amortization of $11,389 and $10,036 at December 31, 2013 and 2012, respectively	8,870	8,805
Other assets	739	581
Total assets	212,594	174,528
Current liabilities:
Accounts payable	2,311	1,057
Accrued royalties	8,435	5,037
Accrued liabilities	5,503	4,671
Accrued compensation and related expenses	1,614	1,121
Deferred tax liabilities, current	181
Deferred revenue	38,168	23,146
Total current liabilities	56,212	35,032
Deferred tax liabilities, noncurrent	6,173	6,474
Other long term liabilities	776	826
Commitments and contingencies
Shareholders' equity:
Common stock, no par value, 75,000 shares authorized; 27,327 and 26,233 shares issued and outstanding at December 31, 2013 and 2012, respectively	166,888	158,020
Accumulated deficit	(17,424)	(25,842)
Accumulated other comprehensive income (loss)	(31)	18
Total shareholders' equity	149,433	132,196
Total liabilities and shareholders' equity	$ 212,594	$ 174,528

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Allowance for doubtful accounts, net	$ 211	$ 142
Accumulated amortization on capitalized software development	13,910	10,987
Accumulated amortization on intangible assets	$ 11,389	$ 10,036
Common stock, no par value
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	27,327	26,233
Common stock, shares outstanding	27,327	26,233

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Statement [Abstract]
Revenues, net	$ 132,274	$ 103,732	$ 82,066
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization)	55,605	41,658	31,066
Product development	11,757	8,610	7,473
Sales and marketing	24,052	19,892	16,017
Other general and administrative expenses	18,342	13,452	10,760
Depreciation and amortization	7,852	6,661	5,412
Total operating costs and expenses	117,608	90,273	70,728
Income from operations	14,666	13,459	11,338
Other income (expense), net	176	118	10
Income before income tax provision	14,842	13,577	11,348
Income tax provision	6,424	5,932	4,404
Net income	$ 8,418	$ 7,645	$ 6,944
Net income per share:
Basic	$ 0.31	$ 0.29	$ 0.31
Diluted	$ 0.30	$ 0.28	$ 0.29
Weighted average shares of common stock outstanding:
Basic	26,853	26,128	22,445
Diluted	27,663	27,507	23,748

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 8,418	$ 7,645	$ 6,944
Other comprehensive income, net of taxes:
Unrealized gain (loss) on marketable securities	(49)	25	(2)
Total other comprehensive income (loss)	(49)	25	(2)
Comprehensive income	$ 8,369	$ 7,670	$ 6,942

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

+ Details

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2010	$ 56,791	$ 97,227	$ (40,431)	$ (5)
Beginning balance, shares at Dec. 31, 2010		21,805
Net income	6,944		6,944
Comprehensive income (loss)	(2)			(2)
Stock based compensation	788	$ 788
Tax benefits from equity awards	21	21
Common stock issued under stock plans, net of shares withheld for employee taxes	1,242	$ 1,242
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		503
Issuance of common stock	55,131	$ 55,131
Issuance of common stock, shares		3,588
Ending balance at Dec. 31, 2011	120,915	$ 154,409	(33,487)	(7)
Ending balance, shares at Dec. 31, 2011		25,896
Net income	7,645		7,645
Comprehensive income (loss)	25			25
Issuance of common stock in acquisition	1,541	$ 1,541
Issuance of common stock in acquisition, shares		56
Stock based compensation	1,136	$ 1,136
Tax benefits from equity awards	111	111
Common stock issued under stock plans, net of shares withheld for employee taxes	823	$ 823
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		281
Ending balance at Dec. 31, 2012	132,196	$ 158,020	(25,842)	18
Ending balance, shares at Dec. 31, 2012		26,233
Net income	8,418		8,418
Comprehensive income (loss)	(49)			(49)
Issuance of common stock in acquisition	534	$ 534
Issuance of common stock in acquisition, shares		15
Stock based compensation	1,458	$ 1,458
Tax benefits from equity awards	3,722	3,722
Common stock issued under stock plans, net of shares withheld for employee taxes	3,154	$ 3,154
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		1,079
Ending balance at Dec. 31, 2013	$ 149,433	$ 166,888	$ (17,424)	$ (31)
Ending balance, shares at Dec. 31, 2013		27,327

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
OPERATING ACTIVITIES:
Net income	$ 8,418	$ 7,645	$ 6,944
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,852	6,661	5,412
Deferred income taxes	2,506	5,601	4,027
Stock based compensation expense	1,458	1,136	788
Excess tax benefits from equity awards	(3,722)	(111)	(21)
Provision for doubtful accounts	115	120	50
Loss on non-marketable equity investments	37	16
Other	1,660	722	83
Changes in assets and liabilities, net of acquisitions:
Accounts and unbilled receivables	(10,056)	1,227	(4,997)
Prepaid royalties	(5,119)	(329)	(263)
Other prepaid expenses and other current assets	(1,207)	(537)	(283)
Other assets	105	(15)	212
Accounts payable	1,254	(1,529)	211
Accrued royalties	3,399	1,579	1,450
Accrued liabilities, accrued compensation and related expenses, and other long-term liabilities	4,822	542	124
Deferred revenue	14,761	(198)	6,018
Net cash provided by operating activities	26,283	22,530	19,755
INVESTING ACTIVITIES:
Acquisitions, net of cash acquired	(7,560)	(9,901)
Proceeds from sales of marketable securities	5,062		2,221
Proceeds from maturities of marketable securities	82,661	78,075	8,135
Purchases of marketable securities	(86,139)	(118,176)	(17,284)
Investments in non-marketable equity investments	(300)	(250)
Payments associated with capitalized software development	(4,267)	(4,435)	(6,065)
Purchases of property and equipment	(4,444)	(4,316)	(4,115)
Net cash used in investing activities	(14,987)	(59,003)	(17,108)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock			55,131
Proceeds from exercise of stock options	3,318	823	1,242
Taxes paid related to net settlement of equity awards	(164)
Excess tax benefits from equity awards	3,722	111	21
Payments on capital lease obligations			(5)
Net cash provided by financing activities	6,876	934	56,389
Net increase (decrease) in cash and cash equivalents	18,172	(35,539)	59,036
Cash and cash equivalents at beginning of year	41,365	76,904	17,868
Cash and cash equivalents at end of year	59,537	41,365	76,904
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	51	61	35
Income taxes paid	371	427	$ 387
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock in connection with acquisitions	$ 534	1,541
Acquisition of content rights in exchange for future services		$ 500

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Reporting Entity and Segments

HealthStream, Inc. (the “Company”) was incorporated in 1990 as a Tennessee corporation and is headquartered in Nashville, Tennessee. We operate our business in two segments: HealthStream Workforce Development Solutions and HealthStream Research/Patient Experience Solutions. Our Workforce Development products consist of SaaS-based services and subscription-based solutions to meet the ongoing training, certification, assessment and development needs of the healthcare community. These solutions provide, deliver and track computer based education for our customers in the United States through our software-as-a-service (SaaS) model. HealthStream Research/Patient Experience products offer healthcare organizations a wide range of quality and satisfaction surveys, consulting services, analyses of survey results, and other research-based services.

Recognition of Revenue

Revenues are derived from providing services through our SaaS-based workforce development platform products, courseware subscriptions, provision of survey and research services, professional services, content maintenance, custom courseware development and other education and training services.

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when persuasive evidence of an arrangement exists, prices are fixed or determinable, services and products are provided to the customer and collectability is probable or reasonably assured.

Revenue recognized from software and other arrangements is allocated to each element of the arrangement based on the relative fair values of the elements. While elements include software products and post contract customer support, the fair value of each element is based on objective evidence specific to the vendor. If fair value cannot be determined for each element of the arrangement, all revenue from the arrangement is deferred until fair value can be determined or until all elements of the arrangement are delivered and customer acceptance has occurred. Sales of the Company’s SaaS-based workforce development platform products include customer support, implementation services, and training; therefore all revenues are deferred until the SaaS-based product is implemented, at which time revenues are recognized ratably over the subscription service period. In the event that circumstances occur, which give rise to uncertainty regarding the collectibility of contracted amounts, revenue recognition is suspended until such uncertainty is resolved. Fees for these services are billed on either a monthly, quarterly, or annual basis.

Revenues derived from the delivery of services through the Company’s SaaS-based workforce development platform products and courseware subscriptions are recognized ratably over the term of the subscription service agreement or over the historical usage period, if usage typically differs from the subscription period. Other training revenues are generally recognized upon the completion of training.

Revenues derived from the license of installed software products, associated with the Sy.Med products, are recognized upon shipment or installation of the software. Software support and maintenance revenues are recognized ratably over the term of the related agreement.

Revenues recognized from the Company’s survey and research services are determined using both the proportional performance method and the completed contract method. Revenues are generally earned over the estimated survey cycle, which typically ranges from less than one month to up to five months. The survey cycle is generally initiated based on the receipt of the first survey response and runs through provision of related survey reports to the customer. If survey results are not available to the customer during the survey fielding cycle, revenues are recognized at time of report delivery. Revenues for coaching and consulting engagements are recognized using the proportional performance method over the term of the underlying contract. Fees for survey services are billed upon initiation of the survey cycle, with progress billings made throughout the survey cycle. Fees for coaching and consulting engagements are billed upon initiation of the engagement with progress billings throughout the term of the contract.

Revenues from professional services, content maintenance, and custom courseware development services are recognized using a percentage of completion method based on labor hours, which correspond to the completion of performance milestones and deliverables. All other revenues are recognized as the related services are performed or products are delivered. Fees for these services are generally billed at project initiation and upon completion of various milestones.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and such differences could be material to the consolidated financial statements.

Cash Equivalents

The Company considers cash equivalents to be unrestricted, highly liquid investments with initial maturities of less than three months.

Marketable Securities

Marketable securities are classified as available for sale and are stated at fair market value, with the unrealized gains and losses, net of tax, reported in other comprehensive income (loss) on the accompanying consolidated balance sheets. Realized gains and losses and declines in market value judged to be other than temporary on investments in marketable securities are included in interest and other income on the accompanying consolidated statements of income. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available for sale are included in other income (expense) on the accompanying consolidated statements of income. Premiums and discounts are amortized over the life of the related available for sale security as an adjustment to yield using the effective interest method.

Accounts Receivable-Unbilled

Accounts receivable-unbilled represents the following: 1) revenue earned and recognized on contracts accounted for using the proportional performance method for which invoices have not been generated or contractual billing dates have not been reached; and 2) the difference between billings for contracts containing escalated pricing over the term of the agreement and the recognition of revenue ratably over the subscription period.

Deferred Revenue

Deferred revenue represents amounts, which have been billed or collected in advance of revenue recognition, and is recognized as the revenue recognition criteria are met. The Company typically invoices customers in quarterly, bi-annual, or annual installments.

Prepaid Royalties

Prepaid royalties represents advance payments associated with the sale of third party products, such as courseware subscriptions. Royalties are typically paid in advance at the commencement of the revenue cycle, or periodically throughout the revenue cycle, such as quarterly, bi-annual, or annual installments. Royalty payments are amortized over the term of the underlying contracts, which generally range from 12 to 36 months, in order to match the direct royalty costs to the same period the subscription revenue is recognized. Amortization of royalties is included under the caption “cost of revenues (excluding depreciation and amortization)” in the accompanying consolidated statements of income.

Allowance for Doubtful Accounts

The Company estimates its allowance for doubtful accounts using a specific identification method. Management determines the allowance for doubtful accounts on a case-by-case basis, based on the facts and circumstances surrounding each potentially uncollectible receivable. An allowance is also maintained for accounts that are not specifically identified that may become uncollectible in the future. Uncollectible receivables are written-off in the period management believes it has exhausted every opportunity to collect payment from the customer. Bad debt expense is recorded when events or circumstances indicate an additional allowance is required based on the Company’s specific identification approach.

Changes in the allowance for doubtful accounts and the amounts charged to bad debt expense for the years ended December 31, were as follows (in thousands):


	Allowance Balance at Beginning of Period		Charged to Costs and Expenses		Write-offs			Allowance Balance at End of Period
2013	$	142	$	115	$	(46	)	$	211
2012	$	149	$	120	$	(127	)	$	142
2011	$	157	$	50	$	(58	)	$	149

Capitalized Software Development

Capitalized software development is stated on the basis of cost, and is presented net of accumulated amortization. The Company capitalizes costs incurred during the software development phase for projects when such costs are material. These assets are amortized using the straight-line method, generally ranging between one to five years. The Company capitalized approximately $4.3 million and $4.4 million during 2013 and 2012, respectively. Maintenance and operating costs are expensed as incurred. As of December 31, 2013 and 2012, there were no capitalized internal development costs for computer software developed for resale.

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used in measuring fair value. There are three levels to the fair value hierarchy based on the reliability of inputs, as follows:


Level 1	–	Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2	–	Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3	–	Unobservable inputs in which little or no market data exists, therefore requiring the Company to develop its own assumptions.

The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level at which to classify them for each reporting period. This determination requires significant judgments to be made by the Company.

At December 31, 2013, the fair value measurement amounts for assets consisted of marketable securities which are classified as available for sale. The carrying amounts reported in the consolidated balance sheets approximate the fair value of the Company’s marketable securities based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. At December 31, 2013 and 2012, the Company did not have any financial liabilities that were subject to fair value measurements.

Property and Equipment

Property and equipment are stated on the basis of cost. Depreciation and amortization are provided on the straight-line method over the following estimated useful lives, except for assets under capital leases and leasehold improvements, which are amortized over the shorter of the estimated useful life or their respective lease term. Depreciation and amortization of property and equipment totaled $3.3 million and $2.6 million for the years ended December 31, 2013 and 2012, respectively.


	Years
Furniture and fixtures		5-10
Equipment		3-5

Goodwill and Intangible Assets

Goodwill represents the excess of purchase price over fair value of net tangible assets acquired. The Company evaluates goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting units using both income and market based models. The Company will perform its goodwill impairment test whenever events or changes in facts or circumstances indicate that impairment may exist, and at least annually during the fourth quarter.

As of December 31, 2013 intangible assets with remaining unamortized balances include contract rights and customer relationships, internally-developed technology and patents, non-competition agreements, and trade names. These intangible assets are considered to have definite useful lives and are being amortized on a straight line basis over periods typically ranging between five and ten years. The weighted average amortization period for definite lived intangible assets as of December 31, 2013 was 8.7 years. Intangible assets are reviewed for impairment whenever events or changes in facts or circumstances indicate that the carrying amount of the assets may not be recoverable. There were no impairments identified or recorded for the years ended December 31, 2013, 2012, or 2011.

Long-Lived Assets

Long-lived assets to be held for use are reviewed for events or changes in facts and circumstances, both internally and externally, which may indicate that an impairment of long-lived assets held for use is present. The Company measures any impairment using observable market values or discounted future cash flows from the related long-lived assets. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. Management periodically evaluates whether the carrying value of long-lived assets, including property and equipment, capitalized software development, other assets and intangible assets will be recoverable. There were no impairments identified or recorded for the years ended December 31, 2013, 2012, or 2011.

Other Assets

Other assets are comprised of the long-term portion of content development fees and non-marketable equity investments.

Non-Marketable Equity Investments

Non-marketable equity investments are accounted for using the equity method when the Company can exercise significant influence over the investee. Investments for which the Company is not able to exercise significant influence over the investee are accounted for under the cost method. The proportionate share of income or loss from equity method investments are recorded under the caption “other income (expense), net” in the accompanying consolidated statements of income.

Financial Instruments

The Company has financial instruments, including cash and cash equivalents, accounts receivable, accounts receivable-unbilled, accounts payable, accrued liabilities, and deferred revenue. The carrying amounts of these financial instruments approximate fair value because of the short term maturity or short term nature of such instruments. Marketable securities approximate fair value based on quoted market prices, see Note 4.

Income Taxes

Income taxes are accounted for using the asset and liability method, whereby deferred tax assets and liabilities are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates that will be in effect for the year in which the differences are expected to affect taxable income. Management evaluates all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed. Future realization of the tax benefit of an existing deductible temporary difference or carryforward ultimately depends on the existence of sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. There are four possible sources of taxable income that may be available under the tax law to realize a tax benefit for deductible temporary differences and carryforwards: 1) future reversals of existing taxable temporary differences, 2) future taxable income exclusive of reversing temporary differences and carryforwards, 3) taxable income in prior carryback year(s) if carryback is permitted under the tax law, and 4) tax-planning strategies that would, if necessary, be implemented to realize deductible temporary differences or carryforwards prior to their expiration. Management reviews the realizability of its deferred tax assets each reporting period to identify whether any significant changes in circumstances or assumptions have occurred that could materially affect the realizability of deferred tax assets. As of December 31, 2013, the Company had established a valuation allowance of $1.3 million for the portion of its net deferred tax assets that are not more likely than not expected to be realized.

The Company accounts for income tax uncertainties using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax positions that meet the more-likely-than-not recognition threshold are measured in order to determine the tax benefit to be recognized in the financial statements. The Company expenses any penalties or interest associated with tax obligations as general and administrative expenses and interest expense, respectively.

Other Long Term Liabilities

Other long term liabilities represent the deferred rent liability associated with an operating lease for office space in Nashville, Tennessee as well as deferred service credits (see Note 9).

Advertising

The Company expenses the costs of advertising as incurred. Advertising expense for the years ended December 31, 2013, 2012, and 2011 was approximately $408,000, $349,000, and $251,000, respectively.

Shipping and Handling Costs

Shipping and handling costs that are associated with our products and services are included in cost of revenues.

Earnings Per Share

Basic earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Common equivalent shares, composed of incremental common shares issuable upon the exercise of stock options, are included in diluted net income per share to the extent these shares are dilutive. Common equivalent shares that have an anti-dilutive effect on diluted net income per share have been excluded from the calculation of diluted weighted average shares outstanding for the years ended December 31, 2013, 2012, and 2011.

Concentrations of Credit Risk and Significant Customers

The Company places its temporary excess cash investments in high quality, short-term money market instruments. At times, such investments may be in excess of the FDIC insurance limits.

The Company sells its products and services to various companies in the healthcare industry that are located in the United States. We perform ongoing credit evaluations of our customers’ financial condition and generally require no collateral from customers. The Company did not have any single customer representing over 10% of net revenues during 2013, 2012, or 2011.

Stock Based Compensation

As of December 31, 2013, the Company maintains two stock based compensation plans, which are described in Note 12. The Company accounts for stock based compensation using the fair-value based method for costs related to share-based payments, including stock options and restricted share units. The Company uses the Black Scholes option pricing model for calculating the fair value of option awards issued under its stock based compensation plan. The Company measures compensation cost of restricted share units based on the closing fair market value of the Company’s stock on the date of grant. Stock based compensation cost is measured at the grant date, based on the fair value of the award that is ultimately expected to vest, and is recognized as an expense over the requisite service period. The Company recognizes tax benefits from stock based compensation if an excess tax benefit is realized. Excess tax benefits are recorded as an increase to common stock when realized.

Newly Issued Accounting Standards

In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (ASU 2013-02), which is effective prospectively for public companies for reporting periods beginning after December 15, 2012. This new accounting standard improves the reporting of reclassifications out of accumulated other comprehensive income (AOCI) by requiring an entity to report the effect of significant reclassifications out of AOCI on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. We adopted this new guidance on January 1, 2013 and the adoption did not have a material effect on our consolidated financial statements.

Shareholders' Equity	12 Months Ended
Shareholders' Equity	Dec. 31, 2013
Equity [Abstract]
Shareholders' Equity	2. SHAREHOLDERS’ EQUITY Common Stock The Company is authorized to issue up to 75 million shares of common stock. The number of common shares issued and outstanding as of December 31, 2013 and 2012 was approximately 27.3 million and 26.2 million, respectively. Preferred Stock The Company is authorized to issue up to 10 million shares of preferred stock in one or more series, having the relative voting powers, designations, preferences, rights and qualifications, limitations or restrictions, and other terms as the Board of Directors may fix in providing for the issuance of such series, without any vote or action of the shareholders. During 2000, all outstanding shares of preferred stock were converted into common stock in connection with our initial public offering (IPO). There have been no shares of preferred stock outstanding since our IPO.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Earnings Per Share

12 Months Ended

Dec. 31, 2013

Earnings Per Share [Abstract]

Earnings Per Share

3. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the three years ended December 31, 2013 (in thousands, except per share amounts):


	2013		2012		2011
Numerator:
Net income	$	8,418	$	7,645	$	6,944

Denominator:
Weighted-average shares outstanding		26,853		26,128		22,445
Effect of dilutive shares		810		1,379		1,303

Weighted-average diluted shares		27,663		27,507		23,748

Basic earnings per share	$	0.31	$	0.29	$	0.31

Diluted earnings per share	$	0.30	$	0.28	$	0.29

Potentially dilutive shares representing approximately 70,000, 105,000, and 247,000 shares of common stock for 2013, 2012, and 2011, respectively, were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.

Marketable Securities

12 Months Ended

Dec. 31, 2013

Investments Debt And Equity Securities [Abstract]

Marketable Securities

4. MARKETABLE SECURITIES

At December 31, 2013 and 2012, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):


	December 31, 2013
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,260	$	—	$	—		$	2,260
Corporate debt securities		46,430		—		(31	)		46,399

Subtotal		48,690		—		(31	)		48,659

Total	$	48,690	$	—	$	(31	)	$	48,659


	December 31, 2012
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 1:
Mutual funds	$	5,042	$	30	$	—		$	5,072

Level 2:
Certificates of deposit		2,254		—		—			2,254
Commercial paper		3,122		1		—			3,123
Corporate debt securities		27,017		1		(17	)		27,001
U.S. government securities		14,499		3		—			14,502

Subtotal		46,892		5		(17	)		46,880

Total	$	51,934	$	35	$	(17	)	$	51,952

The carrying amounts reported in the consolidated balance sheet approximate fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of December 31, 2013, the Company does not consider any of its marketable securities to be other than temporarily impaired. During 2013, the Company recorded realized gains of approximately $5,000 from sales of marketable securities. All investments in marketable securities are classified as a current asset on the balance sheet because the underlying securities mature within one year from the balance sheet date.

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

Business Combinations	12 Months Ended
Business Combinations	Dec. 31, 2013
Business Combinations [Abstract]
Business Combinations	5. BUSINESS COMBINATIONS On June 29, 2012, the Company acquired all of the stock of Decision Critical, Inc., (DCI) an Austin, Texas based company that specializes in learning and competency management products for acute-care hospitals. The Company acquired DCI to further advance its suite of workforce development solutions. The consideration paid for DCI consisted of approximately $3.4 million in cash and 22,124 shares of our common stock. Also, the Company may make additional payments of up to $300,000, contingent upon achievement of certain financial targets and business outcomes within a three year period after the closing date. As of December 31, 2013, approximately $146,000 of these contingent payments have been paid to the DCI shareholders. The Company incurred approximately $203,000 in transaction costs associated with the DCI acquisition, which are included on the accompanying consolidated statements of income under the caption “other general and administrative.” In allocating the purchase price, the Company recorded approximately $2.9 million of goodwill, $1.5 million of identifiable intangible assets, $291,000 of net tangible assets and $456,000 of deferred tax liabilities. The goodwill balance is primarily attributed to assembled workforce, expanded market opportunities from DCI’s workforce development products, and expected synergies from integrating DCI’s products into our platform. The goodwill balance is not deductible for U.S. income tax purposes. The net tangible assets include deferred revenue, which in accordance with US GAAP, was adjusted down from a book value of $548,000 to an estimated fair value of $356,000. The deferred revenue recorded represents the estimated fair value of the contractual obligation assumed as of the acquisition date. The $192,000 write-down of deferred revenue resulted in lower revenues than would have otherwise been recognized for such services. The results of operations for DCI have been included in the Company’s consolidated financial statements from the date of acquisition, and are included in the HealthStream Workforce Development Solutions segment. On October 19, 2012, the Company acquired all of the stock of Sy.Med Development, Inc. (Sy.Med), a Brentwood, Tennessee based company that specializes in credentialing related software products for healthcare providers. The Company acquired Sy.Med to further advance its suite of workforce development solutions. The consideration paid for Sy.Med consisted of approximately $7.4 million in cash and 34,060 shares of our common stock. The Company may make additional payments of up to $1.5 million, contingent upon achievement of certain financial targets and business outcomes within a two year period after the closing date. As of December 31, 2013, approximately $625,000 of these contingent payments have been paid to the Sy.Med shareholders. The Company incurred approximately $165,000 in transaction costs associated with the Sy.Med acquisition, which are included on the accompanying consolidated statements of income under the caption “other general and administrative.” In allocating the purchase price, the Company recorded approximately $5.4 million of goodwill, $6.5 million of identifiable intangible assets, $294,000 of net tangible assets and $2.8 million of deferred tax liabilities. The goodwill balance is primarily attributed to assembled workforce, additional market opportunities of Sy.Med’s credentialing software, and expected synergies from integrating Sy.Med’s products into our platform. The goodwill balance is not deductible for U.S. income tax purposes. The net tangible assets include deferred revenue, which was adjusted down from a book value of $1.1 million to an estimated fair value of $229,000. The $916,000 write-down of deferred revenue resulted in lower revenues than would have otherwise been recognized for such services. The results of operations for Sy.Med have been included in the Company’s consolidated financial statements from the date of acquisition, and are included in the HealthStream Workforce Development Solutions segment. On September 9, 2013, the Company acquired substantially all of the assets of Baptist Leadership Group (BLG), a Pensacola, Florida based company that provides consulting services focused on patient-centered performance excellence in healthcare. The Company acquired BLG to strengthen its Research/Patient Experience Solutions. The consideration paid for BLG consisted of approximately $7.4 million in cash (taking into account the working capital adjustment) and 15,230 shares of our common stock. The Company incurred approximately $145,000 in transaction costs associated with the acquisition, which are included on the accompanying consolidated statements of income under the caption “other general and administrative.” In allocating the purchase price, the Company recorded approximately $6.3 million of goodwill, $1.6 million of identifiable intangible assets, and $28,000 of net tangible assets. The goodwill balance is primarily attributed to the assembled workforce, additional market opportunities from BLG’s consulting services, and expected synergies from integrating BLG into the operations of the HealthStream Research/Patient Experience Solutions segment. The goodwill balance is deductible for U.S. income tax purposes. The net tangible assets include deferred revenue, which was adjusted down from a book value of $508,000 to an estimated fair value of $254,000. The $254,000 write-down of deferred revenue resulted in lower revenues than would have otherwise been recognized for such services. The results of operations for BLG have been included in the Company’s consolidated financial statements from the date of acquisition, and are included in the HealthStream Research/Patient Experience Solutions segment.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

+ Details

Goodwill

12 Months Ended

Dec. 31, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill

6. GOODWILL

Goodwill is evaluated for impairment at least annually to determine whether it is more likely than not that the fair value of the reporting units exceed their carrying value. If this assessment concludes that is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Qualitative factors are considered for this assessment, such as, financial performance, industry and market comparables, and other factors affecting the reporting unit. If the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting units using both income and market based models. Under these methods, the technique used to determine fair value is sensitive to estimates and assumptions associated with cash flow from operations and its growth, discount rates, and reporting unit terminal values. The Company performs its annual impairment evaluation of goodwill during the fourth quarter of each year and as changes in facts and circumstances indicate impairment exists. During the annual impairment evaluation in the fourth quarter of 2013 and 2012, the results of our assessment indicated goodwill was not impaired.

During 2013, the Company acquired Baptist Leadership Group, and during 2012, the Company acquired Decision Critical, Inc. and Sy.Med Development, Inc. The changes in the carrying amount of goodwill for the years ended December 31, 2013 and 2012 are as follows (in thousands):


	Workforce Development		Research/Patient Experience		Total
Balance at January 1, 2013	$	11,459	$	17,840	$	29,299
Acquisition of Sy.Med Development, Inc.		133		—		133
Acquisition of Baptist Leadership Group		—		6,314		6,314

Balance at December 31, 2013	$	11,592	$	24,154	$	35,746


	Workforce Development		Research/Patient Experience		Total
Balance at January 1, 2012	$	3,307	$	17,840	$	21,147
Acquisition of Sy.Med Development, Inc.		5,291		—		5,291
Acquisition of Decision Critical, Inc.		2,861		—		2,861

Balance at December 31, 2012	$	11,459	$	17,840	$	29,299

Intangible Assets

12 Months Ended

Dec. 31, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

7. INTANGIBLE ASSETS

All intangible assets are considered to have finite useful lives. Customer related intangibles are amortized over their estimated useful lives ranging from eight to ten years. Other intangible assets include non-competition agreements, technology and patents, and trade names, and are being amortized over periods ranging from five to nine years. Amortization of intangible assets was approximately $1.5 million, $1.1 million, and $0.9 million, for the years ended December 31, 2013, 2012 and 2011, respectively.

Identifiable intangible assets are comprised of the following (in thousands):


	As of December 31, 2013							As of December 31, 2012
	Gross Amount		Accumulated Amortization			Net		Gross Amount		Accumulated Amortization			Net
Customer related	$	16,889	$	(10,145	)	$	6,744	$	15,619	$	(8,969	)	$	6,650
Other		3,370		(1,244	)		2,126		3,222		(1,067	)		2,155

Total	$	20,259	$	(11,389	)	$	8,870	$	18,841	$	(10,036	)	$	8,805

The expected future annual amortization expense for the years ending December 31, is as follows (in thousands):


2014	$	1,569
2015		1,211
2016		1,122
2017		1,092
2018		990
Thereafter		2,886

Total	$	8,870

Collaborative Arrangement	12 Months Ended
Collaborative Arrangement	Dec. 31, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Collaborative Arrangement	8. COLLABORATIVE ARRANGEMENT The Company participates in a collaborative arrangement, SimVentures^TM, with Laerdal Medical A/S (Laerdal Medical). The Company receives 50 percent of the profits or losses generated from this collaborative arrangement. The parties did not form a separate legal entity as part of the collaborative arrangement; therefore, the Company accounts for SimVentures as a collaborative arrangement in accordance with applicable accounting guidance. For the year ended December 31, 2013, the Company recorded approximately $2.3 million of revenues and $2.3 million of expenses related to the collaborative arrangement. For the year ended December 31, 2012, the Company recorded approximately $1.7 million of revenues and $1.7 million of expenses related to the collaborative arrangement. The Company also recorded approximately $0.9 million and $1.3 million of capitalized software development costs for SimVentures during 2013 and 2012, respectively.

Content Rights and Deferred Service Credits	12 Months Ended
Content Rights and Deferred Service Credits	Dec. 31, 2013
Nonmonetary Transactions [Abstract]
Content Rights and Deferred Service Credits	9. CONTENT RIGHTS AND DEFERRED SERVICE CREDITS During 2012, the Company entered into a renewal agreement with a customer in which the Company was provided continued rights to distribute and resell courseware owned by the customer. In exchange for the receipt of an exclusive license to distribute and resell this courseware, the Company has provided, and will continue to provide, the customer with service credits that can be exchanged for future purchases of the Company’s products and services. The value assigned to the content rights and the deferred service credits was $500,000, which represents the estimated fair value of the assets relinquished. The content rights are classified within other prepaid expenses and other assets, and the deferred service credits are classified within accrued liabilities and other long-term liabilities on our condensed consolidated balance sheets. These exchangeable service credits will be issued annually through December 31, 2016, and will expire twenty-four months after issuance. Any unused credits will be forfeited upon expiration. During 2012 and 2013, the Company issued exchangeable service credits of $100,000, respectively, in accordance with this agreement, and is obligated to issue remaining service credits of $100,000 annually through 2016. The content rights are being amortized on a straight-line basis through December 31, 2016. Revenues for products or services provided in exchange for these service credits will be recognized in accordance with the Company’s revenue recognition policies.

Business Segments

12 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Business Segments

10. BUSINESS SEGMENTS

The Company provides services to healthcare organizations and other members within the healthcare industry. These services are primarily focused on the delivery of workforce development products and services (HealthStream Workforce Development Solutions, formerly referred to as HealthStream Learning & Talent Management), as well as survey and research services (HealthStream Research/Patient Experience Solutions).

The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The Unallocated component below includes corporate functions, such as accounting, human resources, legal, investor relations, administrative, and executive personnel, depreciation, a portion of amortization, and certain other expenses, which are not currently allocated in measuring segment performance. The following is the Company’s business segment information as of and for the years ended December 31, 2013, 2012 and 2011 (in thousands).


	Year ended December 31, 2013
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	103,820	$	28,454	$	—		$	132,274
Cost of revenues (excluding depreciation and amortization)		39,478		16,127		—			55,605
Product development		10,262		1,495		—			11,757
Sales and marketing		18,301		5,415		336			24,052
Other general and administrative		3,787		1,530		13,025			18,342
Depreciation and amortization		3,512		1,068		3,272			7,852

Total income from operations	$	28,480	$	2,819	$	(16,633	)	$	14,666

*Segment assets	$	60,013	$	34,727	$	117,854		$	212,594

Purchases of property and equipment	$	2,598	$	171	$	1,675		$	4,444

Payments associated with capitalized software development	$	3,712	$	555	$	—		$	4,267


	Year ended December 31, 2012
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	78,566	$	25,166	$	—		$	103,732
Cost of revenues (excluding depreciation and amortization)		28,390		13,268		—			41,658
Product development		7,040		1,570		—			8,610
Sales and marketing		14,081		5,420		391			19,892
Other general and administrative		2,760		1,330		9,362			13,452
Depreciation and amortization		2,877		1,179		2,605			6,661

Total income from operations	$	23,418	$	2,399	$	(12,358	)	$	13,459

*Segment assets	$	46,693	$	23,978	$	103,857		$	174,528

Purchases of property and equipment	$	1,728	$	120	$	2,468		$	4,316

Payments associated with capitalized software development	$	3,536	$	899	$	—		$	4,435


	Year ended December 31, 2011
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	58,078	$	23,988	$	—		$	82,066
Cost of revenues (excluding depreciation and amortization)		18,842		12,224		—			31,066
Product development		5,907		1,566		—			7,473
Sales and marketing		10,871		4,733		413			16,017
Other general and administrative		2,116		1,632		7,012			10,760
Depreciation and amortization		2,364		1,194		1,854			5,412

Total income from operations	$	17,978	$	2,639	$	(9,279	)	$	11,338

*Segment assets	$	27,322	$	26,088	$	100,827		$	154,237

Purchases of property and equipment	$	1,577	$	44	$	2,494		$	4,115

Payments associated with capitalized software development	$	5,720	$	345	$	—		$	6,065

Segment assets include accounts and unbilled receivables, prepaid royalties, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

Income Taxes

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Income Taxes

11. INCOME TAXES

The provision for income taxes is comprised of the following (in thousands):


	Year Ended December 31,
	2013		2012		2011
Current federal	$	2,474	$	58	$	163
Current state		1,444		273		214
Deferred federal		2,315		4,804		3,723
Deferred state		191		797		304

Provision for income taxes	$	6,424	$	5,932	$	4,404

A reconciliation of income taxes at the statutory federal income tax rate to the provision for income taxes included in the accompanying consolidated statements of income is as follows (in thousands):


	Year Ended December 31,
	2013		2012		2011
Federal tax provision at the statutory rate	$	5,194	$	4,751	$	3,972
State income tax provision, net of federal benefit		898		974		337
Change in state valuation allowance		231		—		—
Other		101		207		95

Provision for income taxes	$	6,424	$	5,932	$	4,404

Management periodically assesses the realizability of its deferred tax assets, and to the extent that a recovery is not likely, a valuation allowance is established to reduce the deferred tax asset to the amount estimated to be recoverable. At December 31, 2013, a valuation allowance of $1.3 million exists, of which $1.1 million is comprised of the portion of net operating loss carryforwards attributable to the exercises of stock options. Any future reductions of the valuation allowance associated with the portion of the deferred tax asset comprised of stock option exercises would be recognized as an increase to common stock.

As of December 31, 2013, the Company had federal and state net operating loss carryforwards of $18.3 million and $13.9 million, respectively. These loss carryforwards will expire in years 2014 through 2024. As of December 31, 2013, $1.1 million of the net operating loss carryforwards deferred tax asset is attributable to the exercise of stock options, and if realized, the tax benefit will be recorded as an increase to common stock.

The Company has research and development tax credit carryforwards of $393,000 that expire in varying amounts through 2033. These credits were recognized in 2013 as a reduction to common stock. As of December 31, 2013, the Company had alternative minimum tax credit carryforwards of $592,000 that are available to offset future regular tax liabilities and they do not expire. Federal income tax payments of $28,000, $189,000 and $194,000, were made during the years ended December 31, 2013, 2012, and 2011, respectively. State income tax payments of $343,000, $238,000, and $193,000 were made during the years ended December 31, 2013, 2012, and 2011, respectively.

A reconciliation of the beginning and ending liability for gross unrecognized tax benefits at December 31, 2013 and 2012, are as follows (in thousands):


	December 31,
	2013		2012
Balance at beginning of year	$	—	$	—
Additions for tax positions in the current year		167		—

Balance at end of year	$	167	$	—

The components of the income tax liability at December 31, 2013 and 2012, are as follows (in thousands):


	December 31,
	2013		2012
Unrecognized tax benefits	$	167	$	—
Accrued interest and penalties		2		—

Balance at end of year	$	169	$	—

None of the $167,000 of unrecognized tax benefits at December 31, 2013, if recognized, would affect the Company’s effective tax rate.

The Company is subject to income taxation at the federal and various state levels. The Company is subject to U.S. federal tax examinations for tax years 2009 through 2013. Loss carryforwards and credit carryforwards generated or utilized in years earlier than 2009 are also subject to examination and adjustment. The Company has no income tax examinations in process.

Deferred federal and state income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of deferred tax assets and deferred tax liabilities are as follows (in thousands):


	December 31,
	2013			2012
Deferred tax assets:
Allowance for doubtful accounts	$	84		$	57
Accrued liabilities		1,225			463
Tax credits		702			902
Stock based compensation		966			650
Net operating loss carryforwards		1,256			3,485

Total deferred tax assets		4,233			5,557
Less: Valuation allowance		(1,325	)		(1,093	)

Deferred tax assets, net of valuation allowance		2,908			4,464
Deferred tax liabilities:
Deductible goodwill		2,020			1,492
Nondeductible intangible assets		2,677			3,194
Prepaid assets		781			538
Capitalized software development		2,910			2,253
Deferred revenue		—			220
Depreciation		341			223
Basis difference on investments		533			559

Total deferred tax liabilities		9,262			8,479

Net deferred tax liabilities	$	(6,354	)	$	(4,015	)

Stock Based Compensation

12 Months Ended

Dec. 31, 2013

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Based Compensation

12. STOCK BASED COMPENSATION

Stock Incentive Plans

The Company’s 2010 Stock Incentive Plan (2010 Plan) and 2000 Stock Incentive Plan (2000 Plan; collectively, the 2010 Plan and the 2000 Plan referred to as the Plan) authorize the grant of options, restricted share units (RSU), or other forms of stock based compensation to employees, officers, directors and others, and such grants must be approved by the Compensation Committee of the Board of Directors. Options granted under the Plan have terms of no more than ten years, with certain restrictions. The Plan allows the Compensation Committee of the Board of Directors to determine the vesting period and parameters of each grant. The vesting period of the options and RSUs granted has historically ranged from immediate vesting to annual vesting up to four years, beginning one year after the grant date. As of December 31, 2013, approximately 813,000 shares of unissued common stock remained reserved for future stock incentive grants under the Plan. The Company issues new shares of common stock when options are exercised or when RSUs become vested.

Stock Option Activity

A summary of activity and various other information relative to stock options for the year ended December 31, 2013 is presented in the tables below (in thousands, except exercise price).


				Weighted-
	Common			Average		Aggregate
	Shares			Exercise Price		Intrinsic Value
Outstanding at beginning of period		1,914		$	4.29
Granted		—			—
Exercised		(1,073	)		3.15
Expired		—			—
Forfeited		(4	)		6.11

Outstanding at end of period		837		$	5.73	$	22,514

Exercisable at end of period		594		$	5.06	$	16,375

The aggregate intrinsic value for stock options in the table above represents the total difference between the Company’s closing stock price on December 31, 2013 (the last trading day of the year) of $32.63 and the option exercise price, multiplied by the number of in-the-money options as of December 31, 2013. The weighted average remaining contractual term of options outstanding at December 31, 2013 was 3.8 years. Options exercisable at December 31, 2013 have a weighted average remaining contractual term of 3.4 years.

Other information relative to option activity during the three years ended December 31, 2013 is as follows (in thousands, except weighted average grant date fair value):


	2013		2012		2011
Weighted average grant date fair value of stock options granted	$	—	$	—	$	4.67

Total grant date fair value of stock options vested	$	723	$	878	$	644

Total intrinsic value of stock options exercised	$	25,846	$	4,992	$	4,539

Cash proceeds from exercise of stock options	$	3,318	$	823	$	1,242

Restricted Share Unit Activity

A summary of activity relative to RSUs for the year ended December 31, 2013 is follows (in thousands, except weighted average grant date fair value):


	Number of RSU’s			Weighted- Average Grant Date Fair Value		Aggregate Intrinsic Value
Outstanding at beginning of period		73		$	23.22
Granted		80			22.02
Vested		(16	)		23.07
Forfeited		—			—

Outstanding at end of period		137		$	22.53	$	4,466

The aggregate fair value of RSU awards that vested in 2013, as of the respective vesting dates, was approximately $345,000. A portion of RSUs that vested in 2013 were net-share settled such that the Company withheld shares with value equivalent to the employees’ minimum statutory obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. The total shares withheld for RSUs during 2013 were 2,210, and were based on the value of the RSUs on their respective vesting dates as determined by the Company’s closing stock price. One stock option exercise was net-share settled during 2013, resulting in 7,606 shares withheld for settlement of employee tax obligations. Total payments related to RSUs and stock options for the employees’ tax obligations to taxing authorities were approximately $164,000 in 2013, and are reflected as a financing activity within the Consolidated Statements of Cash Flows. These net-share settlements had the effect of share repurchases by the Company as they reduced and retired the number of shares that would have otherwise been issued as a result of the vesting and did not represent an expense to the Company.

Stock Based Compensation

Total stock based compensation expense recorded for the three years ended December 31, 2013, which is recorded in our statements of income, is as follows (in thousands):


	Years Ended December 31,
	2013		2012		2011
Cost of revenues (excluding depreciation and amortization)	$	81	$	45	$	41
Product development		144		133		179
Sales and marketing		175		151		104
Other general and administrative		1,058		807		464

Total stock based compensation expense	$	1,458	$	1,136	$	788

The Company amortizes the fair value of all stock based awards, net of estimated forfeitures, on a straight-line basis over the requisite service period, which generally is the vesting period. As of December 31, 2013, total unrecognized compensation expense related to non-vested stock options and RSU’s was approximately $2.5 million, net of estimated forfeitures, with a weighted average expense recognition period remaining of 2.3 years. The Company realized approximately $3.7 million of excess tax benefits during the year ended December 31, 2013, which was recorded as an increase to common stock.

Stock based compensation cost for RSU’s is measured based on the closing fair market value of the Company’s stock on the date of grant. Stock based compensation cost for stock options is estimated at the grant date based on the fair value calculated using the Black-Scholes method. The Company did not grant any stock options during 2013 or 2012. The ranges of assumptions used for determining the estimated fair value of stock options during 2011 were as follows:


Risk-free interest rate		1.05 – 2.39%
Expected dividend yield		0.0%
Expected life (in years)		5 to 7
Expected forfeiture rate		0-5%
Volatility		50%

Risk-free interest rate is based on the U.S. Treasury rate in effect at the time of the option grant having a term equivalent to the expected life of the option.

Expected dividend yield is zero because the Company has not made any dividend payments in its history and does not plan to pay dividends in the foreseeable future.

Expected life is the period of time the option is expected to remain outstanding, and is based on historical experience. The contractual option life ranges from eight to ten years. The Company estimated the expected life of options granted to members of management to be five years and seven years for directors.

Expected forfeiture rate is the estimated percentage of options granted that are not expected to become fully vested. This estimate is based on historical experience, and will be adjusted as necessary to match the actual forfeiture experience.

Volatility is the measure of the amount by which the price is expected to fluctuate. The Company estimated volatility based on the actual historical volatility of the Company’s common stock, and management believes future volatility will be similar to the Company’s historical volatility experience.

Employee Benefit Plan	12 Months Ended
Employee Benefit Plan	Dec. 31, 2013
Compensation And Retirement Disclosure [Abstract]
Employee Benefit Plan	13. EMPLOYEE BENEFIT PLAN 401(k) Plan The Company has a defined-contribution employee benefit plan (401(k) Plan) incorporating provisions of Section 401(k) of the Internal Revenue Code. Employees must have attained the age of 21 and have completed thirty days of service to be eligible to participate in the 401(k) Plan. Under the provisions of the 401(k) Plan, a plan member may make contributions, on a tax-deferred basis, not to exceed 20% of compensation, subject to IRS limitations. The Company has not provided matching contributions through December 31, 2013.

Debt

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Debt

14. DEBT

At December 31, 2013 and 2012, the Company had no debt outstanding.

Revolving Credit Facility

The Company maintains a Loan Agreement (the “Revolving Credit Facility”) with SunTrust Bank (“SunTrust”) in the aggregate principal amount of $20.0 million, which matures on July 21, 2014. The obligations under the revolving credit facility are guaranteed by each of the Company’s subsidiaries. The Company’s borrowings under the revolving credit facility bear interest at the 30-Day LIBOR Rate plus a margin of either 175 or 200 basis points determined in accordance with a pricing grid. Principal is payable in full on the maturity date. The Company is required to pay a commitment fee of 25 basis points per annum of the average daily unused portion of the revolving credit facility.

The purpose of the revolving credit facility is for general working capital needs, permitted acquisitions (as defined in the Loan Agreement), and for stock repurchase and/or redemption transactions that the Company may authorize.

The revolving credit facility contains certain covenants that, among other things, restrict additional indebtedness, liens and encumbrances, changes to the character of the Company’s business, acquisitions, asset dispositions, mergers and consolidations, sale or discount of receivables, creation or acquisitions of additional subsidiaries, and other matters customarily restricted in such agreements.

In addition, the revolving credit facility requires the Company to meet certain financial tests, including, without limitation:

•

a maximum total leverage ratio (consolidated debt/consolidated EBITDA) of 2.0 to 1.0;

•

funded debt to total capitalization may not exceed 40%; and

•

tangible net worth may not be less than $1.00

As of December 31, 2013, the Company believes it was in compliance with all covenants. There were no balances outstanding on the revolving credit facility as of December 31, 2013.

Leases

12 Months Ended

Dec. 31, 2013

Leases [Abstract]

Leases

15. LEASES

The Company has non-cancellable operating leases primarily for office space and office equipment. Some lease agreements contain provisions for escalating rent payments over the initial terms of the lease. The Company accounts for these leases by recognizing rent expense on a straight-line basis and adjusting the deferred rent expense liability for the difference between the straight-line rent expense and the amount of rent paid. The Company also leases certain office equipment under operating leases. Total rent expense under all operating leases was approximately $2.4 million, $2.2 million, and $1.9 million, for the years ended December 31, 2013, 2012, and 2011, respectively.

Future rental payment commitments at December 31, 2013 under non-cancelable operating leases, with initial terms of one year or more, are as follows (in thousands):


2014	$	2,665
2015		2,062
2016		1,359
2017		446
2018		59
Thereafter		—

Total minimum lease payments	$	6,591

Litigation	12 Months Ended
Litigation	Dec. 31, 2013
Commitments And Contingencies Disclosure [Abstract]
Litigation	16. LITIGATION In the ordinary course of business, the Company is from time to time involved in various pending legal actions. The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon the financial condition and/or results of operations of the Company. However, in the opinion of the Company’s management, matters currently pending or threatened against the Company are not expected to have a material adverse effect on the financial position or results of operations of the Company.

Subsequent Event	12 Months Ended
Subsequent Event	Dec. 31, 2013
Subsequent Events [Abstract]
Subsequent Event	17. SUBSEQUENT EVENT On March 3, 2014, the Company acquired all of the stock of Health Care Compliance Strategies, Inc. (HCCS) a Jericho, New York based company that specializes in healthcare compliance solution and services. The Company acquired HCCS to further advance its suite of workforce development solutions, including its offering of compliance solutions. The consideration paid for HCCS consisted of approximately $13.0 million in cash, subject to a post-closing working capital adjustment, and 81,614 shares of our common stock. The Company may make additional payments of up to $750,000, contingent upon achievement of certain performance milestones post-closing.

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Reporting Entity and Segments

Reporting Entity and Segments

Recognition of Revenue

Recognition of Revenue

Principles of Consolidation

Principles of Consolidation

Use of Estimates

Use of Estimates

Cash Equivalents

Cash Equivalents

The Company considers cash equivalents to be unrestricted, highly liquid investments with initial maturities of less than three months.

Marketable Securities

Marketable Securities

Accounts Receivable-Unbilled

Accounts Receivable-Unbilled

Deferred Revenue

Deferred Revenue

Prepaid Royalties

Prepaid Royalties

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

Changes in the allowance for doubtful accounts and the amounts charged to bad debt expense for the years ended December 31, were as follows (in thousands):


	Allowance Balance at Beginning of Period		Charged to Costs and Expenses		Write-offs			Allowance Balance at End of Period
2013	$	142	$	115	$	(46	)	$	211
2012	$	149	$	120	$	(127	)	$	142
2011	$	157	$	50	$	(58	)	$	149

Capitalized Software Development

Capitalized Software Development

Fair Value Measurements

Fair Value Measurements


Level 1	–	Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2	–	Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3	–	Unobservable inputs in which little or no market data exists, therefore requiring the Company to develop its own assumptions.

Property and Equipment

Property and Equipment


	Years
Furniture and fixtures		5-10
Equipment		3-5

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Long-Lived Assets

Long-Lived Assets

Other Assets

Other Assets

Other assets are comprised of the long-term portion of content development fees and non-marketable equity investments.

Non-Marketable Equity Investments

Non-Marketable Equity Investments

Financial Instruments

Financial Instruments

Income Taxes

Income Taxes

Other Long Term Liabilities

Other Long Term Liabilities

Other long term liabilities represent the deferred rent liability associated with an operating lease for office space in Nashville, Tennessee as well as deferred service credits (see Note 9).

Advertising

Advertising

The Company expenses the costs of advertising as incurred. Advertising expense for the years ended December 31, 2013, 2012, and 2011 was approximately $408,000, $349,000, and $251,000, respectively.

Shipping and Handling Costs

Shipping and Handling Costs

Shipping and handling costs that are associated with our products and services are included in cost of revenues.

Earnings Per Share

Earnings Per Share

Concentrations of Credit Risk and Significant Customers

Concentrations of Credit Risk and Significant Customers

The Company places its temporary excess cash investments in high quality, short-term money market instruments. At times, such investments may be in excess of the FDIC insurance limits.

Stock Based Compensation

Stock Based Compensation

Newly Issued Accounting Standards

Newly Issued Accounting Standards

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Changes in the Allowance for Doubtful Accounts and the Amounts Charged to Bad Debt Expense

Changes in the allowance for doubtful accounts and the amounts charged to bad debt expense for the years ended December 31, were as follows (in thousands):


	Allowance Balance at Beginning of Period		Charged to Costs and Expenses		Write-offs			Allowance Balance at End of Period
2013	$	142	$	115	$	(46	)	$	211
2012	$	149	$	120	$	(127	)	$	142
2011	$	157	$	50	$	(58	)	$	149

Estimated Useful Lives of Property and Equipment


	Years
Furniture and fixtures		5-10
Equipment		3-5

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2013

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three years ended December 31, 2013 (in thousands, except per share amounts):


	2013		2012		2011
Numerator:
Net income	$	8,418	$	7,645	$	6,944

Denominator:
Weighted-average shares outstanding		26,853		26,128		22,445
Effect of dilutive shares		810		1,379		1,303

Weighted-average diluted shares		27,663		27,507		23,748

Basic earnings per share	$	0.31	$	0.29	$	0.31

Diluted earnings per share	$	0.30	$	0.28	$	0.29

Marketable Securities (Tables)

12 Months Ended

Dec. 31, 2013

Investments Debt And Equity Securities [Abstract]

Fair Value of Available for Sale Marketable Securities

At December 31, 2013 and 2012, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):


	December 31, 2013
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,260	$	—	$	—		$	2,260
Corporate debt securities		46,430		—		(31	)		46,399

Subtotal		48,690		—		(31	)		48,659

Total	$	48,690	$	—	$	(31	)	$	48,659


	December 31, 2012
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 1:
Mutual funds	$	5,042	$	30	$	—		$	5,072

Level 2:
Certificates of deposit		2,254		—		—			2,254
Commercial paper		3,122		1		—			3,123
Corporate debt securities		27,017		1		(17	)		27,001
U.S. government securities		14,499		3		—			14,502

Subtotal		46,892		5		(17	)		46,880

Total	$	51,934	$	35	$	(17	)	$	51,952

Goodwill (Tables)

12 Months Ended

Dec. 31, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill for the years ended December 31, 2013 and 2012 are as follows (in thousands):


	Workforce Development		Research/Patient Experience		Total
Balance at January 1, 2013	$	11,459	$	17,840	$	29,299
Acquisition of Sy.Med Development, Inc.		133		—		133
Acquisition of Baptist Leadership Group		—		6,314		6,314

Balance at December 31, 2013	$	11,592	$	24,154	$	35,746


	Workforce Development		Research/Patient Experience		Total
Balance at January 1, 2012	$	3,307	$	17,840	$	21,147
Acquisition of Sy.Med Development, Inc.		5,291		—		5,291
Acquisition of Decision Critical, Inc.		2,861		—		2,861

Balance at December 31, 2012	$	11,459	$	17,840	$	29,299

Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Identifiable Intangible Assets

Identifiable intangible assets are comprised of the following (in thousands):


	As of December 31, 2013							As of December 31, 2012
	Gross Amount		Accumulated Amortization			Net		Gross Amount		Accumulated Amortization			Net
Customer related	$	16,889	$	(10,145	)	$	6,744	$	15,619	$	(8,969	)	$	6,650
Other		3,370		(1,244	)		2,126		3,222		(1,067	)		2,155

Total	$	20,259	$	(11,389	)	$	8,870	$	18,841	$	(10,036	)	$	8,805

Expected Annual Amortization Expense

The expected future annual amortization expense for the years ending December 31, is as follows (in thousands):


2014	$	1,569
2015		1,211
2016		1,122
2017		1,092
2018		990
Thereafter		2,886

Total	$	8,870

Business Segments (Tables)

12 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Business Segment Information Based on Net Revenues and Net Income from Operations

The following is the Company’s business segment information as of and for the years ended December 31, 2013, 2012 and 2011 (in thousands).


	Year ended December 31, 2013
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	103,820	$	28,454	$	—		$	132,274
Cost of revenues (excluding depreciation and amortization)		39,478		16,127		—			55,605
Product development		10,262		1,495		—			11,757
Sales and marketing		18,301		5,415		336			24,052
Other general and administrative		3,787		1,530		13,025			18,342
Depreciation and amortization		3,512		1,068		3,272			7,852

Total income from operations	$	28,480	$	2,819	$	(16,633	)	$	14,666


	Year ended December 31, 2012
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	78,566	$	25,166	$	—		$	103,732
Cost of revenues (excluding depreciation and amortization)		28,390		13,268		—			41,658
Product development		7,040		1,570		—			8,610
Sales and marketing		14,081		5,420		391			19,892
Other general and administrative		2,760		1,330		9,362			13,452
Depreciation and amortization		2,877		1,179		2,605			6,661

Total income from operations	$	23,418	$	2,399	$	(12,358	)	$	13,459


	Year ended December 31, 2011
	Workforce Development		Research/Patient Experience		Unallocated			Consolidated
Revenues, net	$	58,078	$	23,988	$	—		$	82,066
Cost of revenues (excluding depreciation and amortization)		18,842		12,224		—			31,066
Product development		5,907		1,566		—			7,473
Sales and marketing		10,871		4,733		413			16,017
Other general and administrative		2,116		1,632		7,012			10,760
Depreciation and amortization		2,364		1,194		1,854			5,412

Total income from operations	$	17,978	$	2,639	$	(9,279	)	$	11,338

Business Segment Information Based on Assets

The following is the Company’s business segment information as of and for the years ended December 31, 2013, 2012 and 2011 (in thousands).


	Year ended December 31, 2013
	Workforce Development		Research/Patient Experience		Unallocated		Consolidated

*Segment assets	$	60,013	$	34,727	$	117,854	$	212,594

Purchases of property and equipment	$	2,598	$	171	$	1,675	$	4,444

Payments associated with capitalized software development	$	3,712	$	555	$	—	$	4,267


	Year ended December 31, 2012
	Workforce Development		Research/Patient Experience		Unallocated		Consolidated

*Segment assets	$	46,693	$	23,978	$	103,857	$	174,528

Purchases of property and equipment	$	1,728	$	120	$	2,468	$	4,316

Payments associated with capitalized software development	$	3,536	$	899	$	0	$	4,435


	Year ended December 31, 2011
	Workforce Development		Research/Patient Experience		Unallocated		Consolidated


*Segment assets	$	27,322	$	26,088	$	100,827	$	154,237

Purchases of property and equipment	$	1,577	$	44	$	2,494	$	4,115

Payments associated with capitalized software development	$	5,720	$	345	$	0	$	6,065

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Summary of Provision for Income Taxes

The provision for income taxes is comprised of the following (in thousands):


	Year Ended December 31,
	2013		2012		2011
Current federal	$	2,474	$	58	$	163
Current state		1,444		273		214
Deferred federal		2,315		4,804		3,723
Deferred state		191		797		304

Provision for income taxes	$	6,424	$	5,932	$	4,404

Reconciliation of Income Taxes at the Statutory Federal Income Tax Rate to the Provision for Income Taxes


	Year Ended December 31,
	2013		2012		2011
Federal tax provision at the statutory rate	$	5,194	$	4,751	$	3,972
State income tax provision, net of federal benefit		898		974		337
Change in state valuation allowance		231		—		—
Other		101		207		95

Provision for income taxes	$	6,424	$	5,932	$	4,404

Reconciliation of the Beginning and Ending liability for Gross Unrecognized Tax Benefits

A reconciliation of the beginning and ending liability for gross unrecognized tax benefits at December 31, 2013 and 2012, are as follows (in thousands):


	December 31,
	2013		2012
Balance at beginning of year	$	—	$	—
Additions for tax positions in the current year		167		—

Balance at end of year	$	167	$	—

Components of the Income Tax Liability

The components of the income tax liability at December 31, 2013 and 2012, are as follows (in thousands):


	December 31,
	2013		2012
Unrecognized tax benefits	$	167	$	—
Accrued interest and penalties		2		—

Balance at end of year	$	169	$	—

Significant Components of Deferred Tax Assets and Deferred Tax Liabilities

Significant components of deferred tax assets and deferred tax liabilities are as follows (in thousands):


	December 31,
	2013			2012
Deferred tax assets:
Allowance for doubtful accounts	$	84		$	57
Accrued liabilities		1,225			463
Tax credits		702			902
Stock based compensation		966			650
Net operating loss carryforwards		1,256			3,485

Total deferred tax assets		4,233			5,557
Less: Valuation allowance		(1,325	)		(1,093	)

Deferred tax assets, net of valuation allowance		2,908			4,464
Deferred tax liabilities:
Deductible goodwill		2,020			1,492
Nondeductible intangible assets		2,677			3,194
Prepaid assets		781			538
Capitalized software development		2,910			2,253
Deferred revenue		—			220
Depreciation		341			223
Basis difference on investments		533			559

Total deferred tax liabilities		9,262			8,479

Net deferred tax liabilities	$	(6,354	)	$	(4,015	)

Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2013

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Activity and Various Other Information Relative to Stock Options

A summary of activity and various other information relative to stock options for the year ended December 31, 2013 is presented in the tables below (in thousands, except exercise price).


				Weighted-
	Common			Average		Aggregate
	Shares			Exercise Price		Intrinsic Value
Outstanding at beginning of period		1,914		$	4.29
Granted		—			—
Exercised		(1,073	)		3.15
Expired		—			—
Forfeited		(4	)		6.11

Outstanding at end of period		837		$	5.73	$	22,514

Exercisable at end of period		594		$	5.06	$	16,375

Other Information Relative to Option Activity

Other information relative to option activity during the three years ended December 31, 2013 is as follows (in thousands, except weighted average grant date fair value):


	2013		2012		2011
Weighted average grant date fair value of stock options granted	$	—	$	—	$	4.67

Total grant date fair value of stock options vested	$	723	$	878	$	644

Total intrinsic value of stock options exercised	$	25,846	$	4,992	$	4,539

Cash proceeds from exercise of stock options	$	3,318	$	823	$	1,242

Summary of Activity Relative to RSU's

A summary of activity relative to RSUs for the year ended December 31, 2013 is follows (in thousands, except weighted average grant date fair value):


	Number of RSU’s			Weighted- Average Grant Date Fair Value		Aggregate Intrinsic Value


Outstanding at beginning of period		73		$	23.22
Granted		80			22.02
Vested		(16	)		23.07
Forfeited		—			—

Outstanding at end of period		137		$	22.53	$	4,466

Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income

Total stock based compensation expense recorded for the three years ended December 31, 2013, which is recorded in our statements of income, is as follows (in thousands):


	Years Ended December 31,
	2013		2012		2011
Cost of revenues (excluding depreciation and amortization)	$	81	$	45	$	41
Product development		144		133		179
Sales and marketing		175		151		104
Other general and administrative		1,058		807		464

Total stock based compensation expense	$	1,458	$	1,136	$	788

Fair Value of Stock Options Granted, Assumptions

The ranges of assumptions used for determining the estimated fair value of stock options during 2011 were as follows:


Risk-free interest rate		1.05 – 2.39%
Expected dividend yield		0.0%
Expected life (in years)		5 to 7
Expected forfeiture rate		0-5%
Volatility		50%

Leases (Tables)

12 Months Ended

Dec. 31, 2013

Leases [Abstract]

Future Rental Payment Commitments under Non-Cancelable Operating Leases

Future rental payment commitments at December 31, 2013 under non-cancelable operating leases, with initial terms of one year or more, are as follows (in thousands):


2014	$	2,665
2015		2,062
2016		1,359
2017		446
2018		59
Thereafter		—

Total minimum lease payments	$	6,591

Summary of Significant Accounting Policies - Additional Information (Detail)		12 Months Ended
	Dec. 31, 2013 USD ($) Plans	Dec. 31, 2013 USD ($) Customer Segment SourcesofTaxableIncome	Dec. 31, 2012 USD ($) Customer	Dec. 31, 2011 USD ($) Customer
Business And Basis Of Presentation [Line Items]
Number of operating segments \| Segment		2
Maturity of unrestricted cash equivalent		3 months
Capitalized software development amount		$ 4,300,000	$ 4,400,000
Capitalized internal development costs for computer software developed for resale		0	0
Depreciation and amortization of property and equipment		$ 3,300,000	2,600,000
Finite lived intangible assets amortization period		8 years 8 months 12 days
Impairments identified or recorded		$ 0	0	$ 0
Impairments identified or recorded for long-lived assets		$ 0	0	0
Number of sources of taxable income \| SourcesofTaxableIncome		4
Valuation allowance	$ 1,325,000	$ 1,325,000	1,093,000
Advertising expense		$ 408,000	$ 349,000	$ 251,000
Number of stock based compensation plans \| Plans	2
Sales [Member]
Business And Basis Of Presentation [Line Items]
Customer representing over 10% of net revenues		10.00%	10.00%	10.00%
Number of customer single customer representing over 10% of net revenues \| Customer		0	0	0
Minimum [Member]
Business And Basis Of Presentation [Line Items]
Revenues earned over the estimated survey cycle, period		1 month
Royalty payments amortization period		12 months
Assets amortized cost		1 year
Finite lived intangible assets amortization period		5 years
Maximum [Member]
Business And Basis Of Presentation [Line Items]
Revenues earned over the estimated survey cycle, period		5 months
Royalty payments amortization period		36 months
Assets amortized cost		5 years
Finite lived intangible assets amortization period		10 years

Summary of Significant Accounting Policies - Changes in the Allowance for Doubtful Accounts and the Amounts Charged to Bad Debt Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accounting Policies [Abstract]
Allowance Balance at Beginning of Period	$ 142	$ 149	$ 157
Charged to Costs and Expenses	115	120	50
Write-offs	(46)	(127)	(58)
Allowance Balance at End of Period	$ 211	$ 142	$ 149

Summary of Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Detail)	12 Months Ended
	Dec. 31, 2013
Minimum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life	5 years
Minimum [Member] \| Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life	3 years
Maximum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life	10 years
Maximum [Member] \| Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life	5 years

Shareholders' Equity - Additional Information (Detail) - shares shares in Thousands	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	27,327	26,233
Common stock, shares outstanding	27,327	26,233
Preferred stock, shares authorized	10,000
Preferred stock, shares outstanding	0

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Numerator:
Net income	$ 8,418	$ 7,645	$ 6,944
Denominator:
Weighted-average shares outstanding	26,853	26,128	22,445
Effect of dilutive shares	810	1,379	1,303
Weighted-average diluted shares	27,663	27,507	23,748
Basic earnings per share	$ 0.31	$ 0.29	$ 0.31
Diluted earnings per share	$ 0.30	$ 0.28	$ 0.29

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Earnings Per Share - Additional Information (Detail) - shares	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]
Total number of common equivalent shares excluded from the calculations of diluted earnings per share	70,000	105,000	247,000

Marketable Securities - Fair Value of Available for Sale Marketable Securities (Detail) - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	$ 48,690	$ 51,934
Available for sale securities, Unrealized Gains		35
Available for sale securities, Unrealized Losses	(31)	(17)
Available for sale securities, Fair Value	48,659	51,952
Level 2 [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	48,690	46,892
Available for sale securities, Unrealized Gains		5
Available for sale securities, Unrealized Losses	(31)	(17)
Available for sale securities, Fair Value	48,659	46,880
Level 2 [Member] \| Certificates of Deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	2,260	2,254
Available for sale securities, Fair Value	2,260	2,254
Level 2 [Member] \| Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	46,430	27,017
Available for sale securities, Unrealized Gains		1
Available for sale securities, Unrealized Losses	(31)	(17)
Available for sale securities, Fair Value	$ 46,399	27,001
Level 2 [Member] \| Commercial Paper [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		3,122
Available for sale securities, Unrealized Gains		1
Available for sale securities, Fair Value		3,123
Level 2 [Member] \| U.S. Government Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		14,499
Available for sale securities, Unrealized Gains		3
Available for sale securities, Fair Value		14,502
Level 1 [Member] \| Mutual Funds [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		5,042
Available for sale securities, Unrealized Gains		30
Available for sale securities, Fair Value		$ 5,072

Marketable Securities - Additional Information (Detail)	12 Months Ended
Marketable Securities - Additional Information (Detail)	Dec. 31, 2013 USD ($)
Amortized Cost And Fair Value Debt Securities [Abstract]
Realized gains from sale of marketable securities	$ 5,000

Business Combinations - Additional Information (Detail) - USD ($)					12 Months Ended
	Dec. 31, 2013	Sep. 09, 2013	Oct. 19, 2012	Jun. 29, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Business Acquisition [Line Items]
Purchase price allocation for goodwill	$ 35,746,000				$ 35,746,000	$ 29,299,000	$ 21,147,000
Baptist Leadership Group [Member]
Business Acquisition [Line Items]
Acquisition date of assets		Sep. 09, 2013
Consideration paid for acquisition in cash		$ 7,400,000
Consideration paid for acquisition in shares		15,230
Transaction costs associated with the DCI acquisition		$ 145,000
Purchase price allocation for goodwill		6,300,000
Purchase price allocation for identifiable intangible assets		1,600,000
Purchase price allocation for net tangible assets		28,000
Net tangible assets include deferred revenue book value		508,000
Net tangible assets include deferred revenue estimated fair value		254,000
Write-down of deferred revenue		$ 254,000
Decision Critical, Inc. [Member]
Business Acquisition [Line Items]
Acquisition date of assets				Jun. 29, 2012
Consideration paid for acquisition in cash				$ 3,400,000
Consideration paid for acquisition in shares				22,124
Additional consideration paid for acquisition in cash				$ 300,000
Contingent upon achievement of certain financial targets and business outcome, term				3 years
Contingent payments have been paid to the DCI shareholders	146,000
Transaction costs associated with the DCI acquisition				$ 203,000
Purchase price allocation for goodwill				2,900,000
Purchase price allocation for identifiable intangible assets				1,500,000
Purchase price allocation for net tangible assets				291,000
Purchase price allocation for deferred tax liabilities				456,000
Net tangible assets include deferred revenue book value				548,000
Net tangible assets include deferred revenue estimated fair value				356,000
Write-down of deferred revenue				$ 192,000
Sy. Med Development, Inc. [Member]
Business Acquisition [Line Items]
Acquisition date of assets					Oct. 19, 2012
Consideration paid for acquisition in cash			$ 7,400,000
Consideration paid for acquisition in shares			34,060
Additional consideration paid for acquisition in cash			$ 1,500,000
Contingent upon achievement of certain financial targets and business outcome, term			2 years
Contingent payments have been paid to the DCI shareholders					$ 625,000
Transaction costs associated with the DCI acquisition	165,000				165,000
Purchase price allocation for goodwill	5,400,000				5,400,000
Purchase price allocation for identifiable intangible assets	6,500,000				6,500,000
Purchase price allocation for net tangible assets	294,000				294,000
Purchase price allocation for deferred tax liabilities	2,800,000				2,800,000
Net tangible assets include deferred revenue book value	1,100,000				1,100,000
Net tangible assets include deferred revenue estimated fair value	$ 229,000				229,000
Write-down of deferred revenue					$ 916,000

Goodwill - Summary of Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Line Items]
Goodwill, beginning balance	$ 29,299	$ 21,147
Goodwill, ending balance	35,746	29,299
Sy. Med Development, Inc. [Member]
Goodwill [Line Items]
Goodwill acquired	133	5,291
Goodwill, ending balance	5,400
Baptist Leadership Group [Member]
Goodwill [Line Items]
Goodwill acquired	6,314
Decision Critical, Inc. [Member]
Goodwill [Line Items]
Goodwill acquired		2,861
Workforce Development [Member]
Goodwill [Line Items]
Goodwill, beginning balance	11,459	3,307
Goodwill, ending balance	11,592	11,459
Workforce Development [Member] \| Sy. Med Development, Inc. [Member]
Goodwill [Line Items]
Goodwill acquired	133	5,291
Workforce Development [Member] \| Decision Critical, Inc. [Member]
Goodwill [Line Items]
Goodwill acquired		2,861
Research/Patient Experience [Member]
Goodwill [Line Items]
Goodwill, beginning balance	17,840	17,840
Goodwill, ending balance	24,154	$ 17,840
Research/Patient Experience [Member] \| Baptist Leadership Group [Member]
Goodwill [Line Items]
Goodwill acquired	$ 6,314

Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	8 years 8 months 12 days
Amortization of intangible assets	$ 1.5	$ 1.1	$ 0.9
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	5 years
Minimum [Member] \| Customer Related [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	8 years
Minimum [Member] \| Other [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	5 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	10 years
Maximum [Member] \| Customer Related [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	10 years
Maximum [Member] \| Other [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of intangible assets	9 years

Intangible Assets - Identifiable Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 20,259	$ 18,841
Accumulated Amortization	(11,389)	(10,036)
Total	8,870	8,805
Customer Related [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Amount	16,889	15,619
Accumulated Amortization	(10,145)	(8,969)
Total	6,744	6,650
Other [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Amount	3,370	3,222
Accumulated Amortization	(1,244)	(1,067)
Total	$ 2,126	$ 2,155

Intangible Assets - Expected Annual Amortization Expense (Detail) - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Goodwill And Intangible Assets Disclosure [Abstract]
2014	$ 1,569
2015	1,211
2016	1,122
2017	1,092
2018	990
Thereafter	2,886
Total	$ 8,870	$ 8,805

Collaborative Arrangement - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Payments associated with capitalized software development	$ 4,267	$ 4,435	$ 6,065
Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Profits or losses received from collaborative arrangement	50.00%
Revenues related to collaborative arrangement	$ 2,300	1,700
Expenses related to collaborative arrangement	2,300	1,700
Collaborative Arrangement [Member] \| SimVentures [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Payments associated with capitalized software development	$ 900	$ 1,300

Content Rights and Deferred Service Credits - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred Revenue Arrangement [Line Items]
Value assigned to content rights and the deferred service credits	$ 500,000
Exchangeable service credits expiration period	24 months
Exchangeable service credits issued during period	$ 100,000	$ 100,000
Exchangeable remaining service credits to be issued	$ 100,000
Acquisition of Content Rights in Exchange for Future Services [Member]
Deferred Revenue Arrangement [Line Items]
Content rights and deferred service credits, description	The Company entered into a renewal agreement with a customer in which the Company was provided continued rights to distribute and resell courseware owned by the customer. In exchange for the receipt of an exclusive license to distribute and resell this courseware, the Company has provided, and will continue to provide, the customer with service credits that can be exchanged for future purchases of the Company’s products and services.

Business Segments - Business Segment Information Based on Net Revenues and Net Income from Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues, net	$ 132,274	$ 103,732	$ 82,066
Cost of revenues (excluding depreciation and amortization)	55,605	41,658	31,066
Product development	11,757	8,610	7,473
Sales and marketing	24,052	19,892	16,017
Other general and administrative	18,342	13,452	10,760
Depreciation and amortization	7,852	6,661	5,412
Income from operations	14,666	13,459	11,338
Operating Segments [Member] \| Workforce Development [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues, net	103,820	78,566	58,078
Cost of revenues (excluding depreciation and amortization)	39,478	28,390	18,842
Product development	10,262	7,040	5,907
Sales and marketing	18,301	14,081	10,871
Other general and administrative	3,787	2,760	2,116
Depreciation and amortization	3,512	2,877	2,364
Income from operations	28,480	23,418	17,978
Operating Segments [Member] \| Research/Patient Experience [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues, net	28,454	25,166	23,988
Cost of revenues (excluding depreciation and amortization)	16,127	13,268	12,224
Product development	1,495	1,570	1,566
Sales and marketing	5,415	5,420	4,733
Other general and administrative	1,530	1,330	1,632
Depreciation and amortization	1,068	1,179	1,194
Income from operations	2,819	2,399	2,639
Unallocated [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Sales and marketing	336	391	413
Other general and administrative	13,025	9,362	7,012
Depreciation and amortization	3,272	2,605	1,854
Income from operations	$ (16,633)	$ (12,358)	$ (9,279)

Business Segments - Business Segment Information Based on Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]
Segment assets	$ 212,594	$ 174,528	$ 154,237
Purchases of property and equipment	4,444	4,316	4,115
Payments associated with capitalized software development	4,267	4,435	6,065
Operating Segments [Member] \| Workforce Development [Member]
Segment Reporting Information [Line Items]
Segment assets	60,013	46,693	27,322
Purchases of property and equipment	2,598	1,728	1,577
Payments associated with capitalized software development	3,712	3,536	5,720
Operating Segments [Member] \| Research/Patient Experience [Member]
Segment Reporting Information [Line Items]
Segment assets	34,727	23,978	26,088
Purchases of property and equipment	171	120	44
Payments associated with capitalized software development	555	899	345
Unallocated [Member]
Segment Reporting Information [Line Items]
Segment assets	117,854	103,857	100,827
Purchases of property and equipment	$ 1,675	$ 2,468	$ 2,494

Income Taxes - Summary of Provision for Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]
Current federal	$ 2,474	$ 58	$ 163
Current state	1,444	273	214
Deferred federal	2,315	4,804	3,723
Deferred state	191	797	304
Provision for income taxes	$ 6,424	$ 5,932	$ 4,404

Income Taxes - Reconciliation of Income Taxes at the Statutory Federal Income Tax Rate to the Provision for Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]
Federal tax provision at the statutory rate	$ 5,194	$ 4,751	$ 3,972
State income tax provision, net of federal benefit	898	974	337
Change in state valuation allowance	231
Other	101	207	95
Provision for income taxes	$ 6,424	$ 5,932	$ 4,404

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Taxes Disclosure [Line Items]
Valuation allowance	$ 1,325,000	$ 1,093,000
Valuation allowance, remaining amount	$ 1,100,000
Description of operating loss carryforward expiration period	Years 2014 through 2024
Net operating loss carryforwards attributable to the exercise of stock options	$ 1,100,000
Research and development tax credit carryforward expiration year	2033
Alternative minimum tax credit carryforward	$ 592,000
Federal income tax payment	28,000	189,000	$ 194,000
State income tax payment	343,000	238,000	193,000
Unrecognized tax benefits	$ 167,000
U.S. federal tax examinations, start	2009
U.S. federal tax examinations, end	2013
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 0
Federal [Member]
Income Taxes Disclosure [Line Items]
Net operating loss carryforwards	18,300,000
State [Member]
Income Taxes Disclosure [Line Items]
Net operating loss carryforwards	13,900,000
Research and Development [Member]
Income Taxes Disclosure [Line Items]
Research and development tax credit carryforward	$ 393,000

Income Taxes - Reconciliation of the Beginning and Ending liability for Gross Unrecognized Tax Benefits (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Balance at beginning of year
Additions for tax positions in the current year	167,000
Balance at end of year	$ 167,000

Income Taxes - Components of the Income Tax Liability (Detail) - USD ($)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 167,000
Accrued interest and penalties	2,000
Balance at end of year	$ 169,000

Income Taxes - Significant Components of Deferred Tax Assets and Deferred Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:
Allowance for doubtful accounts	$ 84	$ 57
Accrued liabilities	1,225	463
Tax credits	702	902
Stock based compensation	966	650
Net operating loss carryforwards	1,256	3,485
Total deferred tax assets	4,233	5,557
Less: Valuation allowance	(1,325)	(1,093)
Deferred tax assets, net of valuation allowance	2,908	4,464
Deferred tax liabilities:
Deductible goodwill	2,020	1,492
Nondeductible intangible assets	2,677	3,194
Prepaid assets	781	538
Capitalized software development	2,910	2,253
Deferred revenue		220
Depreciation	341	223
Basis difference on investments	533	559
Total deferred tax liabilities	9,262	8,479
Net deferred tax liabilities	$ (6,354)	$ (4,015)

Stock Based Compensation - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unissued common stock reserved for future stock option grants	813,000
Closing stock price	$ 32.63
Weighted average remaining contractual term of options, outstanding	3 years 9 months 18 days
Weighted average remaining contractual term of options, exercisable	3 years 4 months 24 days
Payments related to RSUs and stock options for the employees' tax obligations to taxing authorities	$ 164,000
Weighted average expense recognition period	2 years 3 months 18 days
Excess tax benefits realized	$ 3,700,000
Expected dividend yield	0.00%	0.00%
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of RSU awards that vested	$ 345,000
Shares withheld for RSUs	2,210
Stock option exercise net-share settled	7,606
Payments related to RSUs and stock options for the employees' tax obligations to taxing authorities	$ 164,000
Total unrecognized compensation expense related to non-vested stock options	$ 2,500,000
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual option life range	8 years
Expected life (in years)	5 years	5 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual option life range	10 years
Expected life (in years)	7 years	7 years
Maximum [Member] \| RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of the options and RSU's granted	4 years
Maximum [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options granted	10 years

Stock Based Compensation - Summary of Activity and Various Other Information Relative to Stock Options (Detail) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2013 USD ($) $ / shares shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Outstanding at beginning of period, Common Shares \| shares	1,914
Granted, Common Shares \| shares
Exercised, Common Shares \| shares	(1,073)
Expired, Common Shares \| shares
Forfeited, Common Shares \| shares	(4)
Outstanding at end of period, Common Shares \| shares	837
Exercisable at end of period, Common Shares \| shares	594
Outstanding at beginning of period, Weighted-Average Exercise Price \| $ / shares	$ 4.29
Granted, Weighted-Average Exercise Price \| $ / shares
Exercised, Weighted-Average Exercise Price \| $ / shares	3.15
Expired, Weighted-Average Exercise Price \| $ / shares
Forfeited, Weighted-Average Exercise Price \| $ / shares	6.11
Outstanding at end of period, Weighted-Average Exercise Price \| $ / shares	5.73
Exercisable at end of period, Weighted-Average Exercise Price \| $ / shares	$ 5.06
Outstanding at end of period, Aggregate Intrinsic Value \| $	$ 22,514
Exercisable at end of period, Aggregate Intrinsic Value \| $	$ 16,375

Stock Based Compensation - Other Information Relative to Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Weighted average grant date fair value of stock options granted			$ 4.67
Total grant date fair value of stock options vested	$ 723	$ 878	$ 644
Total intrinsic value of stock options exercised	25,846	4,992	4,539
Cash proceeds from exercise of stock options	$ 3,318	$ 823	$ 1,242

Stock Based Compensation - Summary of Activity Relative to RSU's (Detail) - RSUs [Member] $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2013 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at beginning of period, shares \| shares	73
Granted \| shares	80
Vested \| shares	(16)
Forfeited \| shares
Outstanding at end of period, shares \| shares	137
Outstanding at beginning of period, Weighted-Average Grant Date Fair Value \| $ / shares	$ 23.22
Granted, Weighted-Average Grant Date Fair Value \| $ / shares	22.02
Vested, Weighted-Average Grant Date Fair Value \| $ / shares	23.07
Forfeited, Weighted-Average Grant Date Fair Value \| $ / shares
Outstanding at end of period, Weighted-Average Grant Date Fair Value \| $ / shares	$ 22.53
Aggregate intrinsic Value \| $	$ 4,466

Stock Based Compensation - Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$ 1,458	$ 1,136	$ 788
Cost of Revenues (Excluding Depreciation and Amortization) [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	81	45	41
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	144	133	179
Sales and Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	175	151	104
Other General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$ 1,058	$ 807	$ 464

Stock Based Compensation - Fair Value of Stock Option Granted, Assumptions (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, minimum		1.05%
Risk-free interest rate, maximum		2.39%
Expected dividend yield	0.00%	0.00%
Expected forfeiture rate, minimum		0.00%
Expected forfeiture rate, maximum		5.00%
Volatility		50.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (in years)	5 years	5 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (in years)	7 years	7 years

Employee Benefit Plan - Additional Information (Detail)	12 Months Ended
Employee Benefit Plan - Additional Information (Detail)	Dec. 31, 2013
Defined Contribution Pension And Other Postretirement Plans Disclosure [Abstract]
Employees minimum age eligibility to participate in plan	21 years
Minimum number of days required to be eligible for participation in plan	30 days
Maximum contribution allowed to a plan member	20.00%

Debt - Additional Information (Detail) - USD ($)	12 Months Ended
Debt - Additional Information (Detail) - USD ($)	Dec. 31, 2013	Dec. 31, 2012
Line of Credit Facility [Line Items]
Debt outstanding	$ 0	$ 0
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Aggregate principal amount of loan agreement	$ 20,000,000
Maturity date of Loan agreement	Jul. 21, 2014
Interest on borrowings	30-Day LIBOR Rate plus a margin of either 175 or 200 basis points
Period of LIBOR Rate	30 days
Commitment fee paid per annum	0.25%
Balances outstanding on the revolving credit facility	$ 0
Revolving Credit Facility [Member] \| Variable Interest Rate One [Member]
Line of Credit Facility [Line Items]
Variable rate one	1.75%
Revolving Credit Facility [Member] \| Variable Interest Rate Two [Member]
Line of Credit Facility [Line Items]
Variable rate one	2.00%
Revolving Credit Facility [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Maximum total leverage ratio	2.0
Funded debt to total capitalization	40.00%
Revolving Credit Facility [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Maximum total leverage ratio	1.0
Tangible net worth	$ 1.00

Leases - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Leases [Abstract]
Total rent expense under all operating leases	$ 2.4	$ 2.2	$ 1.9

Leases - Future Rental Payment Commitments under Non-Cancelable Operating Leases (Detail) $ in Thousands	Dec. 31, 2013 USD ($)
Leases [Abstract]
2014	$ 2,665
2015	2,062
2016	1,359
2017	446
2018	59
Thereafter
Total minimum lease payments	$ 6,591

Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] - Health Care Compliance Strategies Inc. [Member]	Mar. 03, 2014 USD ($) shares
Subsequent Event [Line Items]
Cash consideration paid for business acquisition	$ 13,000,000
Consideration paid, Shares \| shares	81,614
Additional Payment of Consideration	$ 750,000
Period to achieve certain financial targets and business outcomes	12 months